Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-20

Clinical Trial Update: Chlorproguanil-Dapsone in Pregnant Women [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating chlorproguanil-dapsone in pregnant women with malaria was terminated; no results were reported in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorproguanil-dapsone (Chlorproguanil-dapsone)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Malaria | Phase 1 | Status: TERMINATED